TENS machines and vagus nerve stimulators both deliver electrical impulses through the skin, but they are fundamentally different technologies targeting different neural pathways for different purposes. The confusion between them is widespread — particularly since consumer TENS devices are cheap and widely available, leading people to wonder whether they can use one for vagus nerve stimulation. The short answer is: standard TENS devices are not designed for vagus nerve stimulation, and the two approaches differ in target, mechanism, parameters, and evidence base.
What TENS Actually Is
Transcutaneous electrical nerve stimulation (TENS) is a pain management technique that has been in clinical use since the 1970s. A standard TENS unit delivers electrical pulses through electrode pads placed on the skin near a painful area — a sore lower back, arthritic knee, or stiff neck. The mechanism is primarily gate control theory: electrical stimulation of large-diameter sensory nerve fibres (A-beta fibres) in the skin and muscle “closes the gate” on pain signals carried by smaller C-fibres, reducing pain perception at the spinal cord level.
TENS is non-specific — it stimulates whatever peripheral nerves are under the electrode pads. It does not target any particular nerve and has no specific autonomic nervous system effects. Standard TENS frequencies (2-150 Hz), pulse widths (50-400 microseconds), and electrode placements are optimised for pain modulation, not for activating the vagus nerve or influencing autonomic function.
What Vagus Nerve Stimulation Is
Vagus nerve stimulation (VNS) specifically targets the vagus nerve to modulate autonomic, inflammatory, and central nervous system activity. It comes in two forms:
Implanted VNS. A surgically implanted pulse generator (similar to a pacemaker) wraps an electrode around the left cervical vagus nerve in the neck. This has been FDA-approved since 1997 for drug-resistant epilepsy and since 2005 for treatment-resistant depression. SetPoint Medical’s bioelectronic device for rheumatoid arthritis (FDA approved July 2025) is a newer implanted VNS approach targeting the inflammatory reflex.
Transcutaneous (non-invasive) VNS. These devices stimulate the vagus nerve through the skin without surgery. There are two main approaches:
Auricular taVNS targets the auricular branch of the vagus nerve (ABVN) — the only peripheral branch of the vagus that reaches the skin surface, located at the ear (specifically the tragus and cymba conchae). Devices like the NEMOS (Cerbomed) deliver precisely calibrated stimulation to this specific anatomical target. The stimulation parameters (frequency, pulse width, current) are set to activate vagal afferent fibres, not for general pain modulation.
Cervical nVNS, exemplified by gammaCore (electroCore), delivers stimulation through the skin of the neck over the cervical vagus nerve. gammaCore holds multiple FDA clearances: acute treatment of episodic cluster headache (2017), prevention of cluster headache (2018), acute treatment of migraine in adults (2018), and acute treatment of pain associated with migraine (2023). The gammaCore Sapphire, a newer-generation device, launched in 2024.
Your local vagus nerve experts
Find a vagus nerve practitioner near you
Our directory lists 2,685 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.
Or browse by approach
- Clinician-applied tVNS
- Implanted VNS and neuromodulation
- Polyvagal-informed therapy
- Somatic therapy
- HRV biofeedback
- Craniosacral therapy
The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.
Key Differences
Target. TENS targets generic peripheral sensory nerves at the site of pain. VNS targets the vagus nerve specifically — either surgically at the cervical vagus or transcutaneously at the auricular branch or cervical region.
Mechanism. TENS works via gate control (blocking pain signals at the spinal cord). VNS works via vagal afferent activation → nucleus tractus solitarius → modulation of brainstem, limbic, and cortical circuits, plus activation of the cholinergic anti-inflammatory pathway.
Parameters. TENS devices typically use higher frequencies (80-150 Hz for conventional TENS), wider pulse widths, and variable intensities optimised for sensory nerve recruitment. VNS devices use carefully calibrated parameters (commonly 20-30 Hz, narrow pulse widths) designed specifically for vagal afferent fibre activation. These parameters matter — the wrong frequency or intensity may fail to activate vagal pathways or could activate nociceptive fibres instead.
Electrode placement. TENS pads go on or near the painful area — back, knee, shoulder, anywhere. VNS electrodes go on specific anatomical locations where the vagus nerve is accessible: the ear (tragus/cymba conchae for auricular taVNS) or the neck (over the carotid sheath for cervical nVNS).
Regulatory status. Consumer TENS devices are widely sold without prescription. FDA-cleared VNS devices (gammaCore, implanted VNS systems) have undergone specific clinical trials demonstrating safety and efficacy for their approved indications.
Can You Use a TENS Machine on the Vagus Nerve?
This is the question that drives most of the confusion. Some people place TENS electrodes on their ear (tragus) or neck and assume they are doing vagus nerve stimulation. While the anatomical target might be approximately correct, several problems arise:
Standard TENS devices do not have the precise parameter control needed for optimal vagal afferent activation. The frequency, pulse width, waveform, and current delivery characteristics differ from purpose-built taVNS devices. Using wrong parameters could be ineffective (simply stimulating skin without activating vagal fibres) or could activate the wrong nerve populations.
TENS electrode pads are designed for flat skin surfaces (back, leg), not for the ear. Purpose-built auricular taVNS devices use specialised ear clips or probes that target the cymba conchae or tragus precisely.
Safety considerations differ. The neck contains the carotid sinus, and inappropriate electrical stimulation there can theoretically affect heart rate and blood pressure. Purpose-built cervical VNS devices (gammaCore) include safety features and have been tested for cardiac safety. A consumer TENS unit applied to the neck has not.
This does not mean TENS is useless — it remains a well-supported treatment for many types of pain. But it is a different tool for a different job.
Choosing the Right Approach
For pain management (back pain, arthritis, muscle soreness): a standard TENS device is appropriate and well-supported by evidence. For conditions where vagus nerve modulation is the goal (migraine, cluster headache, inflammation, autonomic regulation): purpose-built VNS devices with clinical evidence for those specific indications are the appropriate choice. gammaCore is the most accessible FDA-cleared option for migraine and cluster headache. Research-grade taVNS devices are used in clinical trials for depression, epilepsy, and inflammatory conditions.
For general vagal toning and autonomic health: the strongest evidence supports non-electrical approaches — slow breathing (especially extended exhalation), cold water face immersion, physical exercise, and adequate sleep. These are free, safe, and have broader evidence for improving heart rate variability and parasympathetic function than any consumer electrical device.
Want the full picture of vagus nerve stimulation — how devices work, which ones have evidence, and how they compare to natural techniques? Get the Vagus Nerve & Me eBook for the definitive guide.
